Phraction Management
TMO icon

Phraction Management’s Thermo Fisher Scientific TMO Stock Holding History

Phraction Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23.3M Sell
34,512
-23
-0.1% -$13.7K 4.27% 7
2026
Q2 		$17.3M Buy
34,535
+2,090
+6% +$1M 2.91% 7
2026
Q1 		$15.9M Buy
32,445
+1,461
+5% +$793K 3.3% 8
2025
Q4 		$18M Sell
30,984
-37
-0.1% -$20.9K 4.78% 6
2025
Q3 		$15M Buy
31,021
+1,055
+4% +$491K 4.34% 5
2025
Q2 		$12.2M Sell
29,966
-198
-0.7% -$82.8K 3.89% 7
2025
Q1 		$15M Buy
30,164
+2,037
+7% +$1.1M 5.03% 3
2024
Q4 		$14.6M Buy
28,127
+527
+2% +$290K 5.13% 4
2024
Q3 		$17.1M Buy
27,600
+395
+1% +$234K 6.04% 3
2024
Q2 		$15M Buy
27,205
+172
+0.6% +$98.5K 5.5% 4
2024
Q1 		$15.7M Sell
27,033
-430
-2% -$241K 6.05% 3
2023
Q4 		$14.6M Buy
27,463
+6,784
+33% +$3.28M 6.02% 4
2023
Q3 		$10.5M Buy
20,679
+2,089
+11% +$1.11M 4.94% 7
2023
Q2 		$9.7M Buy
18,590
+5,255
+39% +$2.84M 4.79% 7
2023
Q1 		$7.69M Buy
13,335
+1,918
+17% +$1.08M 4.41% 8
2022
Q4 		$6.29M Buy
11,417
+100
+0.9% +$53K 4.13% 11
2022
Q3 		$5.74M Buy
11,317
+282
+3% +$158K 4.33% 8
2022
Q2 		$6M Buy
11,035
+950
+9% +$523K 3.94% 7
2022
Q1 		$5.96M Buy
10,085
+510
+5% +$293K 3.43% 7
2021
Q4 		$6.39M Buy
+9,575
New +$5.98M 3.87% 5

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Loring Wolcott & Coolidge Fiduciary Advisors
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Local Pensions Partnership Investment
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 16.58% 1-Year Est. Return

Phraction Management's TMO Position: Q3 2026 in Review

Phraction Management reduced its Thermo Fisher Scientific (TMO) stake by 0.07% in Q3 2026, selling an estimated $13.7K and leaving 34,512 shares worth $23.3M. The position accounts for 4.27% of the portfolio, ranked #7.

Phraction Management first reported a position in TMO in Q4 2021 and has held it in 20 quarters since. 1,023 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Phraction Management held 34,512 shares of Thermo Fisher Scientific worth $23.3M as of Q3 2026.
  • Phraction Management sold 23 Thermo Fisher Scientific shares in Q3 2026, an estimated $13.7K.
  • Thermo Fisher Scientific made up 4.27% of Phraction Management's portfolio in Q3 2026, its #7 holding.
  • Phraction Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 20 quarters since.
  • 1,023 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Phraction Management's 13F filing for Q3 2026, filed 14 Oct 2026.